- New Purchases: CVX , TXN , FLIR , FB, UNH, GE, ABT, ADP, CHKP, GM,
- Added Positions:TMO, C, GOOGL, ISRG, TSM, NKE, ORCL, MCO, MO,
- Reduced Positions:V, PM, ACN, FOXA, JNJ, TWX, MSFT, PEP,
- Sold Out:PFE, K,
For the details of AustralianSuper Pty Ltd's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AustralianSuper+Pty+Ltd
These are the top 5 holdings of AustralianSuper Pty Ltd
- Thermo Fisher Scientific Inc ( TMO ) - 689,898 shares, 5.9% of the total portfolio. Shares added by 73.56%
- Citigroup Inc ( C ) - 1,679,400 shares, 5.52% of the total portfolio. Shares added by 63.37%
- Alphabet Inc ( GOOGL ) - 118,100 shares, 5.19% of the total portfolio. Shares added by 61.78%
- Nike Inc ( NKE ) - 1,955,000 shares, 4.58% of the total portfolio. Shares added by 16.62%
- Chevron Corp ( CVX ) - 834,700 shares, 4.43% of the total portfolio. New Position
New Purchase: Chevron Corp ( CVX )
AustralianSuper Pty Ltd initiated holdings in Chevron Corp. The purchase prices were between $103.04 and $117.99, with an estimated average price of $109.11. The stock is now traded at around $119.73. The impact to the portfolio due to this purchase was 4.43%. The holdings were 834,700 shares as of 2017-09-30.
New Purchase: Texas Instruments Inc (TXN)
AustralianSuper Pty Ltd initiated holdings in Texas Instruments Inc. The purchase prices were between $76.41 and $89.65, with an estimated average price of $82.03. The stock is now traded at around $101.22. The impact to the portfolio due to this purchase was 4.01%. The holdings were 989,500 shares as of 2017-09-30.
New Purchase: FLIR Systems Inc (FLIR)
AustralianSuper Pty Ltd initiated holdings in FLIR Systems Inc. The purchase prices were between $34.1 and $40.66, with an estimated average price of $37.84. The stock is now traded at around $47.38. The impact to the portfolio due to this purchase was 3.71%. The holdings were 2,111,200 shares as of 2017-09-30.
New Purchase: Facebook Inc (FB)
AustralianSuper Pty Ltd initiated holdings in Facebook Inc. The purchase prices were between $148.43 and $173.51, with an estimated average price of $166.52. The stock is now traded at around $180.18. The impact to the portfolio due to this purchase was 3.66%. The holdings were 473,900 shares as of 2017-09-30.
New Purchase: UnitedHealth Group Inc (UNH)
AustralianSuper Pty Ltd initiated holdings in UnitedHealth Group Inc. The purchase prices were between $185.48 and $199.75, with an estimated average price of $193.19. The stock is now traded at around $221.82. The impact to the portfolio due to this purchase was 3.6%. The holdings were 406,600 shares as of 2017-09-30.
New Purchase: General Electric Co (GE)
AustralianSuper Pty Ltd initiated holdings in General Electric Co. The purchase prices were between $23.72 and $27.45, with an estimated average price of $25.26. The stock is now traded at around $17.82. The impact to the portfolio due to this purchase was 1.25%. The holdings were 1,140,700 shares as of 2017-09-30.
Added: Thermo Fisher Scientific Inc ( TMO )
AustralianSuper Pty Ltd added to the holdings in Thermo Fisher Scientific Inc by 73.56%. The purchase prices were between $171.74 and $194.04, with an estimated average price of $181.08. The stock is now traded at around $192.27. The impact to the portfolio due to this purchase was 2.5%. The holdings were 689,898 shares as of 2017-09-30.
Added: Citigroup Inc ( C )
AustralianSuper Pty Ltd added to the holdings in Citigroup Inc by 63.37%. The purchase prices were between $65.95 and $72.74, with an estimated average price of $68.28. The stock is now traded at around $74.77. The impact to the portfolio due to this purchase was 2.14%. The holdings were 1,679,400 shares as of 2017-09-30.
Added: Alphabet Inc ( GOOGL )
AustralianSuper Pty Ltd added to the holdings in Alphabet Inc by 61.78%. The purchase prices were between $919.46 and $998.31, with an estimated average price of $947.7. The stock is now traded at around $1072.00. The impact to the portfolio due to this purchase was 1.98%. The holdings were 118,100 shares as of 2017-09-30.
Added: Intuitive Surgical Inc (ISRG)
AustralianSuper Pty Ltd added to the holdings in Intuitive Surgical Inc by 22.07%. The purchase prices were between $307.22 and $348.79, with an estimated average price of $326.71. The stock is now traded at around $369.87. The impact to the portfolio due to this purchase was 0.76%. The holdings were 265,500 shares as of 2017-09-30.
Added: Taiwan Semiconductor Manufacturing Co Ltd (TSM)
AustralianSuper Pty Ltd added to the holdings in Taiwan Semiconductor Manufacturing Co Ltd by 22.74%. The purchase prices were between $34.5 and $38.3, with an estimated average price of $36.51. The stock is now traded at around $39.50. The impact to the portfolio due to this purchase was 0.73%. The holdings were 2,326,700 shares as of 2017-09-30.
Added: Oracle Corp (ORCL)
AustralianSuper Pty Ltd added to the holdings in Oracle Corp by 49.14%. The purchase prices were between $47.92 and $52.8, with an estimated average price of $49.76. The stock is now traded at around $48.30. The impact to the portfolio due to this purchase was 0.59%. The holdings were 812,800 shares as of 2017-09-30.
Sold Out: Pfizer Inc (PFE)
AustralianSuper Pty Ltd sold out the holdings in Pfizer Inc. The sale prices were between $32.67 and $35.99, with an estimated average price of $33.88.
Sold Out: Kellogg Co (K)
AustralianSuper Pty Ltd sold out the holdings in Kellogg Co. The sale prices were between $62.81 and $70.36, with an estimated average price of $67.36.
Reduced: Visa Inc (V)
AustralianSuper Pty Ltd reduced to the holdings in Visa Inc by 64.65%. The sale prices were between $93.25 and $106.21, with an estimated average price of $101.34. The stock is now traded at around $113.82. The impact to the portfolio due to this sale was -3.24%. AustralianSuper Pty Ltd still held 245,700 shares as of 2017-09-30.
- Warning! GuruFocus has detected 6 Warning Signs with TMO. Click here to check it out.
- TMO 15-Year Financial Data
- The intrinsic value of TMO
- Peter Lynch Chart of TMO
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
